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ABSTRACT  In  both  skeletal  and  cardiac  muscle,  the  dihydropyridine  (DHP) 
receptor is a critical element in excitation-contraction (e-c) coupling. However, the 
mechanism for calcium release is completely different in these muscles.  In cardiac 
muscle the DHP receptor functions as a rapidly-activated calcium channel and the 
influx of calcium through this channel induces calcium release from the sarcoplas- 
mic reticulum (SR).  In contrast, in skeletal muscle the DHP receptor functions as a 
voltage sensor and as a  slowly-activating calcium channel;  in this case,  the voltage 
sensor  controls  SR  calcium  release.  It  has  been  previously  demonstrated  that 
injection of dysgenic myotubes with cDNA (pCAC6) encoding the  skeletal  muscle 
DHP receptor restores the slow calcium current and skeletal type e-c coupling that 
does not require entry of external calcium (Tanabe, Beam, Powell, and Numa. 1988. 
Nature.  336:134-139).  Furthermore,  injection  of cDNA  (pCARD1)  encoding  the 
cardiac DHP receptor produces rapidly activating calcium current and cardiac type 
e-c coupling that does require calcium entry (Tanabe,  Mikami,  Numa, and Beam. 
1990. Nature.  344:451--453). In this paper, we have studied the voltage dependence 
of, and the relationship between, charge movement, calcium transients, and calcium 
current in normal skeletal muscle cells in culture. In addition, we injected pCAC6 or 
pCARD 1 into the nuclei of dysgenic myotubes and studied the relationship between 
the  restored  events  and  compared  them  with  those  of the  normal  cells.  Charge 
movement  and  calcium  currents  were  recorded  with  the  whole  cell  patch-clamp 
technique.  Calcium  transients  were measured with Fluo-3 introduced  through the 
patch  pipette.  The  kinetics  and  voltage  dependence  of the  charge  movement, 
calcium transients,  and  calcium current  in  dysgenic myotubes expressing  pCAC6 
were  qualitatively  similar  to  the  ones  elicited  in  normal  myotubes:  the  calcium 
transient  displayed a  sigmoidal dependence  on voltage and was still  present  after 
the addition of 0.5 mM Cd  2+  +  0.1  mM La  s+. In contrast, the calcium transient in 
dysgenic  myotubes  expressing  pCARD1  followed  the  amplitude  of the  calcium 
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current and  thus  showed a bell shaped  dependence on voltage.  In addition,  the 
transient  had  a  slower rate  of rise  than  in  pCAC6-injected  myotubes  and  was 
abolished completely by the addition of Cd  2+  +  La  3+. 
INTRODUCTION 
In the contraction of both skeletal and cardiac muscle cells, a key event is the release 
of calcium from the sarcoplasmic reticulum (SR), which is elicited as a consequence of 
depolarization of the  plasmalemma.  In  this  process,  termed excitation-contraction 
(e-c)  coupling,  an  essential  plasmalemmal  protein  is  the  dihydropyridine  (DHP) 
receptor (Rfos and Bruin,  1987; Tanabe, Beam, Powell, and Numa,  1988). Although 
the  DHP  receptor is  present  in  both  skeletal  and  cardiac  muscle,  the  mechanism 
controlling the release of calcium from the SR is different in the two cell types.  In 
cardiac  muscle  the  DHP  receptor  functions  as  a  calcium  channel  which,  upon 
depolarization of the membrane, activates with a fast time course to allow the influx 
of calcium  ions  into  the  cell.  This  calcium  influx  triggers  the  opening  of the  SR 
calcium release channel (Fabiato,  1985; N~ibauer, Callewaert, Cleemann, and Morad, 
1989).  In  skeletal  muscle,  the  DHP  receptor  is  thought  to  have  a  dual  role, 
functioning both as a slowly activating calcium channel and as the voltage sensor that 
controls SR calcium release (Rfos and Bruin,  1987; Tanabe et al.,  1988). The concept 
of a  voltage  sensor was  first  suggested  by  Schneider  and  Chandler  (1973),  who 
proposed  that  this  structure  produced  the  nonlinear  capacitative current,  termed 
charge movement, which they found to be present in skeletal muscle. Additionally, 
the possibility was  suggested that  a  mechanical linkage between the voltage sensor 
and the SR could control the release of calcium from the latter structure (Chandler, 
Rakowski, and Schneider, 1976). 
Muscular dysgenesis (mdg)  is a  fatal,  autosomal, recessive mutation  (Gluecksohn- 
Waelsch,  1963) that causes the failure of e-c coupling in skeletal muscle (Powell and 
Fambrough, 1973; Klaus, Scordilis, Rapalus, Briggs, and Powell, 1983). Electrophysi- 
ologically, dysgenic muscle has been shown to lack slowly activating calcium current 
(Beam,  Knudson,  and  Powell,  1986)  and  to  have  a  greatly  reduced  amount  of 
intramembrane  charge  movement  (Adams,  Tanabe,  Mikami,  Numa,  and  Beam, 
1990; Shimahara, Bournaud, Inoue, and Strube,  1990). The mdg mutation alters the 
gene that encodes the skeletal muscle DHP receptor (Tanabe et al.,  1988; Chaudhari, 
1992) with  the result that the translation product of the gene is  absent (Knudson, 
Chaudhari,  Sharp,  Powell,  Beam,  and  Campbell,  1989).  This  absence  appears  to 
account for the phenotypic abnormalities of dysgenic muscle because e-c coupling, 
slow  calcium  current  (Tanabe  et  al.,  1988)  and  intramembrane  charge  movement 
(Adams et al.,  1990) can be restored by the injection of an expression plasmid which 
encodes the skeletal muscle DHP receptor. 
Because  other  proteins  involved  in  e-c  coupling,  including  calsequestrin,  the 
ryanodine  receptor  (postulated  to  he  the  SR  calcium  release  channel)  and  the 
Ca2+/Mg  2+  ATPase of the  SR,  are present  in  skeletal  muscle  from dysgenic mice 
(Knudson et al.,  1989), cultured dysgenic muscle provides an excellent environment 
for expressing DHP receptors in order to study their interaction with the SR release 
channel. Previous studies of DHP receptors expressed in dysgenic muscle (Tanabe et 
al.,  1988,  1990a, b;  Adams  et al.,  1990)  have measured electrical signals  associated 
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only monitored intracellular calcium release very indirectly, by means of electrically 
evoked contractions. In this paper, we have used calcium indicator dyes to obtain a 
more  direct  measurement  of intraceUular  calcium  release.  The  calcium  transients 
were recorded during voltage clamp measurements of calcium current or intramem- 
brane charge movement in cultured normal myotubes or dysgenic myotubes injected 
with plasmids that  encode  the  DHP  receptor of either skeletal (pCAC6)  or cardiac 
muscle  (pCARD1).  This  has  allowed us  to  obtain  a  quantitative  description of the 
relationship between  the calcium transients  and  these  membrane  currents.  Prelimi- 
nary reports of some of the results have appeared (Garcfa, Tanabe, and Beam,  1993; 
Beam and Garcfa,  1993). 
MATERIALS  AND  METHODS 
Electrical and Optical Measurements 
Transmembrane currents were recorded using the whole-cell configuration of the patch-clamp 
technique  (Hamill,  Marty,  Neher,  Sakmann,  and  Sigworth,  1981).  Calcium  transients were 
measured with  the  fluorescent indicator dye  Fluo-3  (Molecular Probes,  Inc.,  Eugene,  OR), 
which was loaded into cells as the pentapotassium salt contained in the whole-cell patch pipette. 
Additional details on recording procedures are described in the preceding paper (Garcfa and 
Beam,  1994).  The prepulse protocol (Adams et al., 1990) was used as voltage clamp command 
sequence  for  the  measurement  of both  calcium  currents  and  charge  movement.  In  this 
protocol, voltage is first stepped from the holding potential (-80 mV) to -30 or -40 mV for 1 
s and then to -50 mV for 25-30 ms, varying test potentials for 15 ms, -50 mV for 25-30 ms, 
and finally back to the holding potential again. The purpose of this protocol was to inactivate 
ionic currents through  sodium and T-type calcium channels, and  to cause immobilization of 
intramembrane charge movements associated with these two channel types, before the  15-ms 
test pulses. Voltage clamp command sequences were applied every 20 s. 
Electrical and  optical signals were sampled simultaneously at either 4  or  10  kHz. Analog 
filtering was  set  at  2  kHz  for  the  electrical recordings  and  at  0.1-1  kHz  for  the  optical 
recordings. All the records shown are single traces for both membrane currents and calcium 
transients. 
Injection and Expression of the Plasmids 
Nuclei  of dysgenic  myotubes  were  microinjected with  the  expression  plasmids  pCAC6  or 
pCARD1 on the sixth to seventh day after initial plating of myoblasts into primary culture. Both 
the procedures for microinjection and for tissue culture were essentially as described in Tanabe 
et al. (19~8). The expression plasmids carry cDNA inserts encoding the rabbit skeletal muscle 
(pCAC6; Tanabe et al., 1988) or the rabbit cardiac muscle (pCARDI; Mikami, Imoto, Tanabe, 
Niidome, Mori, Rakeshima, Narumiya, and Numa,  1989)  DHP receptor. The concentration of 
the cDNA in the injection pipette was 0.5  ~g/wl for pCAC6 and  0.5-1  ~g/p~l for pCARD1. 
Myotubes were examined 2-4 d after the injection. Myotubes expressing the skeletal muscle or 
cardiac DHP receptors were identified by contractions evoked by electrical stimulation (80 V, 
5-ms pulses) applied via a blunt tipped (5 v.m) extracellular pipette positioned near ( < 50 v.m) 
the cell as described earlier (Tanabe et al., 1988;  1990a,b). 
Solutions 
Patch pipettes were made from borosilicate glass and had resistances of 1.6-2.1 MI) when filled 
with  "internal solution," which contained (mM):  145  Cs-aspartate,  10  HEPES,  5  MgzCI,  0.1 
CszEGTA, and 0.2 K~Fluo-3. The external solution contained (mM): 145 TEACI, 10 HEPES,  10 128  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  103  •  1994 
CaCl2, and 0.003 TI'X. For the  measurement  of intramembrane  charge movement,  0.5  mM 
CdCI2 and 0.1  mM LaCls were  added to this external  solution. The pH of all solutions was 
adjusted  to 7.4 with CsOH. 
The bath volume of the recording chamber was  ~ 0.5 ml. The bath was exchanged with at 
least 20 ml of any new solution. Temperature (22-24°C) was monitored with a thermistor probe 
placed within the recording chamber.  Data are presented  as mean _  SEM, with the number of 
experiments  in parentheses. 
RESULTS 
Calcium Transients and Slow Calcium Current in Normal Myotubes 
Fig.  1  shows  the  calcium  transients  and  the  slow  calcium  current  elicited  from  a 
normal  myotube  by  test  pulses  (15  ms  in  duration)  to  the  membrane  potentials 
indicated next to the traces.  Because the prepulse protocol was used  (see  Materials 
and  Methods),  the  recorded  current  represents  the  slow,  dihydropyridine-sensitive 
calcium current with little contamination from other currents. For this particular cell, 
the current was detected at 0 mV, became larger and reached a maximum at 30 mV. 
The maximum amplitude of the calcium current for different cells  (10 mM external 
calcium concentration) was  -2.7  -  0.3 pA/pF (n  -- 31), measured at the end of the 
15-ms pulses. As described in the previous paper, the calcium transient was usually 
detectable for weaker depolarizations than the calcium current and rose more rapidly 
and had a larger amplitude for stronger depolarizations. The average, maximal AF/F 
value for the calcium transient was  1.8  --+- 0.5  (n =  31),  also measured at the end of 
the  15-ms pulse.  Note that the amplitude of the slow calcium current first increased 
and  then  decreased  for  stronger  depolarizations  (as  the  test  depolarization  ap- 
proached  the  reversal  potential),  while  the  amplitude  of  the  calcium  transient 
increased monotonically to a saturating level at test potentials greater than  -- 30 mV. 
Lack of Calcium Transients in Dysgenic Myotubes 
Because dysgenic myotubes do not contract under ordinary conditions in response to 
depolarization (Klaus et al.,  1983; Tanabe et al.,  1988),  they would appear to provide 
an  excellent  "null  background" for studying calcium transients  produced by exog- 
enous  DHP  receptors  introduced  by  injection  of  appropriate  cDNAs.  However, 
consideration must be given to the fact that dysgenic myotubes express a low density 
of an L-type calcium current, termed Idys, that differs from the slow calcium current of 
normal myotubes in several respects, including faster activation kinetics and a higher 
sensitivity to DHPs (Adams and Beam,  1989).  Furthermore,  it has been  shown that 
after Idys has been potentiated by a  DHP agonist (1  ~M Bay K 8644), some dysgenic 
myotubes do display depolarization-induced contractions that depend upon the entry 
of extracellular calcium (Adams and  Beam,  1991).  This  result  raises  the  possibility 
that  in  the  absence of the  DHP agonist, Idys may trigger elevations  of intracellular 
calcium that  are  subthreshold  for eliciting a  visible contraction. To investigate  this 
possibility, we examined the effect of depolarization on intracellular calcium levels in 
control dysgenic myotubes that had not been injected with the cDNAs that encode 
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myotubes  in which  the  density of Idys averaged 0.53  -+  0.12  pA/pF,  similar to  the 
value of 0.48 pA/pF found by Adams and Beam (1991) under comparable conditions. 
Fig. 2 illustrates the results obtained from the dysgenic myotube out of this group of 
eleven that displayed the largest Iays, with a  maximum amplitude of almost 1 pA/pF. 
In  this  cell,  15-ms  depolarizations to  potentials  _<20  mV  did  not  elicit detectable 
calcium transients. A  depolarization to  +30 mV did elicit a  small transient (maximal 
zkF/F  of  0.04),  which  had  a  very  long  delay  with  respect  to  the  onset  of  the 
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Normal  FIGURE  1.  Calcium  transient 
and  calcium  current  in  a  nor- 
mal  myotube.  In  this  and  all 
subsequent  figures,  the  mem- 
brane potential during the test 
pulse (15-ms duration) is indi- 
cated  by  the  number  at  the 
right.  Unless  otherwise  noted, 
the onset of the test pulses oc- 
curred 0.5  ms from the begin- 
ning of the illustrated traces. At 
each test potential, the calcium 
transient  is  the  noisier  trace 
which remains at or above the 
dashed  baseline.  Note  that  a 
small calcium transient was elic- 
ited by a weaker depolarization 
(-10 mV) than that required to 
elicit inward calcium current (0 
mV).  Because the calcium cur- 
rent of normal myotubes is very 
slowly  activating,  the  inward 
current is still increasing at the 
end  of the  15-ms  test  pulses. 
Measured at the end of the test 
pulse, the amplitude of the cur- 
rent first increased with increas- 
ing  test  depolarization  and 
then  decreased  again  for  po- 
tentials > 30 mV. The calcium transient became larger and rose more quickly with increasing 
depolarization up to about +30 mV, beyond which it remained roughly constant. 
depolarization. The  average  maximal  ~/F  elicited by  15  ms  test  pulses  averaged 
0.01  +  0.01  (n =  11). The calcium transient wa~ slightly more prominent when  100- 
to 200-ms  test depolarizations were used  (not shown),  but  still very small (maximal 
ZkF/F of 0.02  -  0.02, n  =  6). In conclusion, for the 15-ms test pulses that we routinely 
used, it seems unlikely that elevations of myoplasmic calcium caused by endogenous 
Iay~ contributed significantly to the calcium transients in dysgenic myotubes express- 
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Calcium Transients and Slow Calcium Current in Dysgenic Myotubes 
Expressing pCAC6 
Previously  it  was  shown  that  injection  of dysgenic  myotubes  with  the  expression 
plasmid  pCAC6 restores  spontaneous  and electrically evoked contractions as well as 
slow calcium current  (Tanabe  et  al.,  1988).  Fig.  3  illustrates  calcium transients  and 
calcium  currents  from  a  dysgenic  myotube  injected  with  pCAC6.  As  in  normal 
myotubes (Garcfa and Beam,  1994), an appreciable calcium transient generally could 
be elicited by a weaker depolarization  (e.g.,  -  10 mV in Fig. 3) than that required  (0 
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FIGURE 2.  Absence of calcium  transient  and  slowly activating calcium  current  in  dysgenic 
myotubes. At each of the indicated  test potentials,  the calcium transient  is illustrated  on the 
upper baseline  and  the membrane current on the lower baseline.  In the current traces,  the 
prominent outward deflection at the onset of the test depolarization  (due to immobilization- 
resistant charge movement) is followed by a small,  inward calcium current, ldy~. Idy~ reaches a 
steady-state level  within  less  than  10  ms,  thus  distinguishing  it from the much more  slowly 
activating calcium current of normal myotubes (compare with Fig.  1).  Note the absence of a 
calcium transient at all test potentials except for a small fluorescence change that occurs after 
repolarization from +30 inV. 
mV  in  Fig.  3)  to  elicit  an  appreciable  slow  calcium  current.  Also  as  in  normal 
myotubes,  the  calcium transient  became larger and faster with  stronger  depolariza- 
tions and saturated in amplitude for potentials of ~  +40 mV and above. The average 
amplitude  of the maximal AF/F was  1.0  +  0.2  (n =  19) in  10 mM external calcium. 
The  slow  calcium  current  in  pCAC6-injected  myotubes  had  activation  kinetics 
resembling  those  of the  slow  calcium  current  of normal  myotubes,  although  the 
maximum amplitude of the expressed current, for a  15-ms test pulse, was -  1.3 -+ 0.3 
pA/pF  (n =  22),  about half that of normal  myotubes.  Consistent with  the  idea  that GARC~ ET At..  Ca  e+ Transients for Expressed Skeletal and Cardiac DHPRs  131 
the  DHP  receptor  can  function  both  as  a  voltage  sensor  controlling  SR  calcium 
release  and  as  a  slowly-activating  calcium  channel  (Tanabe  et  al.,  1988),  all  the 
injected myotubes that contracted in response to electrical stimulation displayed both 
a calcium transient  and a  slow calcium current. 
pCAC6 
-2O 
-10 
0 
10  ms 
~ 
0 
0 
5O 
FIGURE 3.  Calcium  transient  and  slow calcium current  in dysgenic myotubes injected with 
pCAC6. The calcium transient and slow calcium current were restored by injection (2 d before 
recording) of this  dysgenic myotube with the expression plasmid pCAC6, which encodes the 
rabbit  skeletal  muscle  DHP  receptor.  The  calcium  transient  and  the  slow  calcium  current 
restored by pCAC6 resembled those from normal myotubes (Fig.  1). 
Cardiac-Type Calcium  Transient and Calcium Current Restored by pCARD1 
Injection of the expression plasmid pCARD 1 can also restore contraction of dysgenic 
myotubes, although in this case the contraction depends on calcium entry (Tanabe et 
al.,  1990a).  Fig.  4A  shows  the  calcium  transient  and  the  calcium current  recorded 132 
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FIGURE 4.  Calcium  transient  and  calcium  current  in  dysgenic  myotubes  injected  with 
pCARDI.  Dysgenic  myotubes  were  injected  two  days  before  recording  with  the  expression 
plasmid  pCARD1, which encodes  the cardiac muscle  DHP receptor.  (A) Cardiac-like calcium 
current  and  calcium transient  in a  pCARDl-injected myotube. The  calcium current  activates 
with much faster kinetics than in normal (Fig. 1) or pCAC6-injected (Fig. 3) myotubes, reaching 
a  steady  state  level in  < 10  ms for test potentials  > 10 mV. The calcium transient  rises more 
slowly  than  in  normal  or  pCAC6-injected  myotubes.  It  also  differs  in  that  it  follows  the 
amplitude of the calcium current. Thus, at the end of the 15-ms test pulse, the amplitude of the GARCfA ET AL.  Ca  2+ Transients for Expressed Skeletal and Cardiac DHPRs  133 
from a  dysgenic  myotube  injected  with  pCARD1.  The  expressed  calcium  current 
activated  much  more  rapidly,  reaching  a  steady  amplitude  within  15  ms  for  test 
potentials  > 20 mV,  than the current  in normal myotubes or in dysgenic myotubes 
expressing  pCAC6,  which  was  still  increasing  at  the  end  of the  15-ms  test  pulse 
(compare  Figs.  1,  3,  and  4A).  The  average  amplitude  of  the  peak  current  in 
pCARDl-expressing  myotubes  was  -26.4  +  2.2  pA/pF  (n =  17).  The  calcium 
transient  in  dysgenic  myotubes  expressing  pCARD1  (measured  at  the  end  of the 
15-ms  test  pulse)  first  became appreciable  in  response  to  a  test depolarization  of 
either the same magnitude as that required to elicit appreciable calcium current (e.g., 
0 mV in Fig. 4 A ) or, more commonly, for a  test depolarization about 10 mV larger. 
This  is  in  contrast  to  both  normal  myotubes  and  dysgenic  myotubes  expressing 
pCAC6,  in  which  a  weaker  depolarization  was  required  to  elicit  an  appreciable 
calcium transient than was necessary for evoking a  detectable  slow calcium current. 
Another  important  difference  is  that  in  normal  myotubes  and  pCAC6-expressing 
dysgenic myotubes the amplitude of the calcium transient increased monotonically as 
a  function  of test  potential,  whereas  in  pCARDl-injected  myotubes  the  transient 
initially increased  in amplitude for increasing test depolarizations,  reached a  maxi- 
mum (at +30 mV in Fig. 4 A ) and then decreased again for still stronger depolariza- 
tions.  Thus,  the  amplitude  of the  calcium transient  in  pCARDl-injected  myotubes 
mirrors the amplitude of the calcium current. This was particularly evident for very 
strong depolarizations.  For example, when a  pCARDl-injected cell was depolarized 
to near the reversal for calcium current (e.g., +80 or +90 mV for the cell in Fig. 4A), 
both the current and the calcium transient were small during the test pulse.  Upon 
repolarization,  however, there was a  large increase in both the calcium current and 
the calcium transient.  In dysgenic myotubes expressing the cardiac  DHP receptor, 
the relationship between the amplitudes of the calcium current and calcium transient, 
and  their  dependence  on  test  potential,  are  similar  to  their  behavior  in  cardiac 
muscle  (Beuckelman  and  Wier,  1988;  N~ibauer  et  al.,  1989;  Wier,  1990).  The 
maximum  amplitude  of  the  calcium  transient  (AF/F)  in  pCARDl-injected  cells, 
measured at the end of the  15-ms test pulses, was only 0.33  --- 0.06  (n  =  17),  about 
four- or  fivefold smaller than  in  pCAC6-injected  or normal  myotubes,  respectively 
(Table I, column 4). If it is assumed that resting calcium was similar in the pCARD1- 
and pCAC6-injected myotubes, then the difference in AF/F suggests that the cardiac 
DHP  receptor  is  less  effective  than  the  skeletal  muscle  DHP  receptor  in  eliciting 
calcium release in skeletal muscle cells. 
All pCARDl-injected  dysgenic myotubes that contracted  in response to electrical 
stimulation were found to display both a calcium current and a calcium transient,  as 
illustrated  for  the  cell  in  Fig.  4A.  However,  some  pCARDl-injected  cells  that 
displayed  either  a  very  weak  contraction,  or  no  contraction  at  all,  nonetheless 
expressed a high density of L-type calcium current (Fig. 4 B; Discussion). 
transient and current increase and then decrease in parallel for increasing test depolarization. 
At any given test pulse, the transient shows an increase (particularly  noticeable at +80 and +90 
mV) that coincides with the large, inward  tail of calcium current that occurs when potential is 
repolarized at the end of the test pulse.  (B) Example of a cell in which injection  of pCARDI 
resulted in a large current but only a very small transient. A single pulse to 20 mV is shown. 134  rile JOURNAL OF GENERAL PHYSIOLOGY • VOLUME 103  • 1994 
Voltage Dependence  of the  Calcium  Transient and the Calcium  Current 
Fig.  5  shows  the  dependence  on  test  potential  of  calcium  current  (O)  and  the 
normalized  fluorescence  change  (A)  in  a  representative  normal  myotube  (left),  a 
pCAC6-injected  myotube  (center),  and  a  pCARDl-injected  myotube  (right).  For  all 
three,  the  curve  relating  current  to  test  potential  is  U-shaped.  In  normal  and 
pCAC6-injected  myotubes,  the curve relating  the fluorescence change  to  test poten- 
tial  is  S-shaped,  whereas  for  the  pCARDl-injected  myotubes  this  curve  has  an 
inverted  U  shape.  For the current,  the data  have been fitted with the smooth curve 
I  =  Gma,,'(V-Vrev)/[1  +  exp {(V~<l/2)  -  V)lk'c,}],  (1) 
where  G~,ax is  the  maximum  conductance  for a  15-ms  test pulse,  Vrev is  the  reversal 
potential (determined  as one of the fitted parameters),  V is the test potential,  V{;t/2  is 
TABLE  I 
Average Values of Fitted Parameters in Normal and Injected Myotubes 
10 Ca  10 Ca +  0.5 Cd +  0.1  La 
1  2  3  4  5  6  7  8  9  lO  11  12 
G'm,x  V'c.,,2  k'G  AF/Fma,,  Vr':'~  kr  Qma,,  VQ,...z  kQ  AF/Fma~ Vr,,'~  kr 
nS/nF  mV  mV  mV  mV  nC/ll,F  mV  mV  mV  mV 
Normal  104  17  6.6  1.8  4.1  7.7  5.1  1.4  12.7  1.0  13.0  6.6 
+- 17  ±0.9  +0.3  -+0.5  +0.9  +0.4  +0.9  -0.9  -  1.5  -+0.3  -+2.2  -0.7 
(30)  (30)  (30)  (31)  (31)  (31)  (6)  (6)  (6)  (6)  (6)  (6) 
pCAC6  49  24  8.2  1.0  6.6  9.0  4.6  -3.5  14.0  0.6  6.9  8.2 
-+8.8  --+2.6 -+0.5  -+0.2  -+0.9  -+0.6  -+0.5  -+2.5  -+0.8  +0.1  -+1.5  -+0.6 
(17)  (17)  (17)  (19)  (19)  (19)  (4)  (4)  (4)  (10)  (10)  (10) 
pCARD1  319"  6.6*  5.0*  0.3:  --  --  13.6  -0.6  13.3  0~  --  -- 
-+76  -+1.7  +-0.3  -+0.1  -+2.1  -+0.8  -+0.7 
(4)  (4)  (4)  (18)  (8)  (8)  (8) 
*Data shown only for cells with estimated series resistance error _< 10 mV (average of 5.9 -+ 1.4 mV); for cells 
with an error  < 15 mV (n =  10). G'ma× =  329  -+ 39 nS/nF, V'(;,2  =  4.9 -+  1.0 mV, k'c; =  4.4  -+ 0.3 inV. 
++Maximum value obtained without fitting to a sigmoidal curve. ~Blocking the current eliminated the calcium 
transient. 
the  potential  that  elicits  the  half-maximal  increase  in  conductance,  and  k~;  is  a 
steepness  parameter.  For the fluorescence,  the data have been fitted with the smooth 
curve 
AF/F 
-  1/[1  +  exp  {(VF(I/2)  --  V)/kv}],  (2) 
(AF/F)max 
where  (AF/F)  max  is  the  maximum  fluorescence  change,  Vv~/2  is  the  potential  that 
elicits the half-maximal increase in fluorescence change,  and  V and kF have meanings 
as  above.  Average values  for  the  fitted  parameters  (except  VEer) are  summarized  in 
Table I  (columns  1-6).  Note that for pCARDl-injected  myotubes,  no values are given 
for VE~/2 or kv because  the fluorescence change vs potential curve is not described by 
Eq.  2.  Also,  in  the  case  of  the  pCARDl-injected  myotubes,  the  large  size  of the 
expressed  current  (2.2-43.5  nA/cell) and  the resulting  series  resistance  error would GARCfA ET AL.  Ca 2+ Transients for Expressed Skeletal and Cardiac DHPRs  135 
be expected to have the effect of shifting Vo,12 in the hyperpolarizing direction and 
causing the value ofko to be too small; thus, Table I gives values for these parameters 
only  for  the  subset  of pCARDl-injected  myotubes  in  which  the  estimated  series 
resistance error (Imax'R~,ies) was comparatively small. Calculation of VG l/~ and kG was 
less  problematic  in  normal  and  pCAC6-injected  myotubes,  since  both  the  slow 
calcium  current  and  estimated  series  resistance  error was  relatively  small  in  these 
cells. It has been reported that the voltage-dependence for activation of slow calcium 
current differs between normal and pCAC6-injected myotubes (Adams et al.,  1990). 
This was  also  apparent  in  our  experiments  in  that  the  value  of Vott2 for pCAC6- 
injected myotubes was shifted toward the right 7  mV compared to  VGI/2  for normal 
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FIGURE 5.  Comparison of voltage dependence  of calcium  currents  and calcium  transients. 
The amplitude of calcium current (0) and calcium transient (A) is plotted as a function of test 
potential for a  representative normal myotube (left),  pCAC6-injected  myotube (middle),  and 
pCARDl-injected myotube (right).  The  calcium currents are normalized by linear cell capaci- 
tance  and  the  calcium  transient  to  the  maximum amplitude  for each  cell. Smooth  curves 
represent least-squares  fits of Eqs.  1 or 2 for the current and transient data, respectively. The 
broken curve through the calcium transient data for the pCARDl-injected cell, was obtained by 
inverting,  and normalizing to one, the smooth curve through the current data. 
myotubes.  In contrast  to  conductance,  VFJ/~ for the  fluorescence  change  (Table  I, 
column  5)  was  much  more  similar  for  normal  and  pCAC6-injected  myotubes, 
differing by only 2.5 inV. 
The differences in the amplitudes of the calcium current between the three types of 
myotubes are reflected in the values of G'max  for each (normal,  104 nS/nF; pCAC6, 49 
nS/nF;  pCARD1, 329 nS/nF).  Our value of G'~x for pCARDI is close to the value of 
Gmax (488  nS/nF)  found  by Adams  et  al.  (1990),  whereas  the  values  of Gmax for 
normal and pCAC6-injected myotubes are much smaller than the previously reported 
values of Gmax (normal, 459 nS/nF; pCAC6,  141  nS/nF). In large part, this difference 
can be accounted  for by the fact that  the  calcium currents  in normal and  pCAC6- 136  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  103.  1994 
injected  myotubes  have  such  slow  kinetics  that  they  were  much  less  completely 
activated by the  15-ms test pulses used in the present study than by the 200-ms test 
pulses  used  in  the earlier study.  Note that  in addition  to having a  larger value of 
Gmax, pCARDl-injected myotubes had a more negative value of VGI/2 (Table I), which 
also contributes to the larger size of the expressed current in these cells. 
Comparison on a Long Time Base of the Calcium Transients in pCAC6- and 
pCARD l-Injected Myotubes 
Fig.  6  illustrates  1.2-s  recordings  of  the  calcium  transients  elicited  by  15-ms 
depolarizations applied to myotubes injected with either pCAC6 (A) or pCARD1  (B). 
In the pCAC6-injected myotube, the transient in response to a depolarization of -  10 
mV began to decay shortly after repolarization, whereas the transients in response to 
depolarizations of + 10 and  +30 mV continued to increase slowly for several tens of 
ms after the depolarization was terminated. This behavior of the transients is similar 
to  that  reported  for  normal  myotubes  in  the  previous  paper  (Garcia  and  Beam, 
1994).  Although  the  possibility  of dye  saturation  could  not  be  excluded,  it  was 
suggested  that  (a)  the  primary  control  of intracellular  calcium  release  in  normal 
myotubes  involves  a  pathway  rapidly  activated  by  depolarization  and  rapidly  de- 
activated  by  repolarization  and  that  (b)  when  calcium  released  via  this  primary 
pathway exceeds a threshold level, it induces a secondary, regenerative release which 
is manifest as the slow phase of increase of the intracellular calcium transient (Garcla 
and Beam,  1994). 
The calcium transients in pCARDl-injected myotubes had a similar time course for 
test potentials of varying size, although the amplitude of the transient was larger for 
the test pulse to  +40 mV than at either 0  or +90 mV. The variation in amplitude 
correlates  with  the  integral  of calcium  current  (during  the  test  pulse  and  after 
repolarization), which was larger at +40 than at 0 or +90 mV (cf Fig. 4). This is the 
behavior expected if the calcium transient in pCARDl-injected cells is triggered by 
calcium  entry.  The  cell  illustrated  in  Fig.  6 B  was  typical  of  pCARDl-injected 
myotubes in  that  the calcium transients did  not display the phase of slow increase 
that was  present in calcium transients elicited by strong depolarizations applied  to 
pCAC6-injected myotubes (Fig. 6 A ). If it is correct that this slow phase in pCAC6- 
injected myotubes represents a secondary, regenerative release, the absence of a slow 
phase  in  the  transients  of pCARDl-injected  myotubes could  be  explained  if the 
intracellular  calcium  concentration  failed  to  reach  threshold  for  inducing  this 
secondary release. Consistent with this explanation, the smaller amplitude transients 
in  pCAC6-injected  myotubes, which were  typically evoked by weak depolarizations 
(e.g.,  -10  mV  in  Fig.  6A),  had  a  time course similar  to  that  of the  transients  in 
pCARD 1-injected myotubes (Fig. 6 B ). 
Simultaneous Measurement of Calcium Transients and Charge Movements 
After  completion  of  the  simultaneous  measurements  of  calcium  transients  and 
calcium  currents  in  a  cell,  calcium  channel  ionic  currents  were  blocked  by  the 
addition  of Cd 2+  +  La  3+  to  the  bath  to  allow  the  simultaneous  measurement  of 
calcium  transients  and  intramembrane  charge  movements.  In  order to  isolate  the 
immobilization-resistant  charge  movement  that  is  thought  to  arise  predominantly 
from DHP receptors, voltage clamp commands were based on the prepulse protocol GARCiA ET AL. 
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FIGURE 6.  Long time-base recordings of calcium transients restored in dysgenic myotubes by 
pCAC6 (A) and pCARD 1 (B). As in the other figures, the duration of the test pulses was 15 ms. 
The onset of the test pulses occurred 12.5 ms from the beginning of the illustrated transients. 
In A, note that the transient continues to increase after repolarization from the test depolariza- 
tion of either +10 or +30 inV. In B, note that the calcium transient for the test pulse to +90 
mV is caused by calcium entering the cell during the tail current produced by repolarization to 
-50  mV  (cf  Fig.  4A).  Also  note  the  transients  decay  more  rapidly  than  those  of  the 
pCAC6-injected myotube, a  difference that was consistently observed. For both A and B,  the 
test  pulses  are  schematically illustrated below  the  transients.  The  potential preceding  and 
following the test pulses was -50 mV and the last downward step indicates repolarization back 
to the holding potential of -80 mV. 
(Adams  et  al.,  1990).  The  immobilization-resistant charge  movements  in  normal 
myotubes and in dysgenic myotubes injected with pCAC6 or pCARD1  were qualita- 
tively similar (Fig. 7): depolarization caused a  transient, outward movement of charge 
("ON"  transient)  and  repolarization  caused  a  comparably-sized,  transient,  inward 
movement  of charge.  Note that for both normal and pCAC6-injected myotubes,  (a) 
stronger  depolarizations  were  required  to  elicit  a  calcium  transient  than  those 138 
Normal 
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FIGURE  7.  Charge  movements  and  calcium  transients  in  normal  and  injected  dysgenic 
myotubes. Calcium transients (upper trace of each pair) and charge movements (lower trace of 
each pair) were recorded,  after addition of Cd  2*  +  La  3+ to the external solution, from normal 
myotubes (left), pCAC6-injected myotubes (middle),  and pCARDl-injected myotubes (right). The 
transients in normal and pCAC6-injected myotubes were qualitatively similar to those recorded 
before  addition  of  Cd  ~+  +  La  3+  to  the  bath;  the  transient  in  pCARDl-injected  cells  was 
abolished  by  this  addition.  For  normal  and  pCAC6-injected  myotubes,  note  that  charge 
movement was  detectable  for  weaker  depolarizations  than  those  needed  to  elicit  a  calcium 
transient and that the rising phase of the calcium transient lags the rising phase of the ON 
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required  for  charge  movement,  and  (b)  that  for  a  given  test  pulse  the  calcium 
transient  begins  to  rise  only  after  most  of the  charge  has  moved.  To  obtain  a 
quantitative description of the immobilization-resistant charge movements, values of 
Q were determined by integrating the "ON" transient at each test potential (V) and 
fitted according to 
Q  =  Qmax/[1 +  exp {(VQ1/Z - V)/kQ/],  (3) 
where Qmax is the maximum ON charge movement, VQ J/z is the test potential at which 
Q is half-maximal and kQ is a steepness factor. Values obtained for these parameters 
in  normal,  pCAC6-injected  and  pCARDl-injected  myotubes  are  summarized  in 
Table I. 
In agreement with previous results  (Adams  et al.,  1990;  Shimahara  et al.,  1990) 
control (noninjected) dysgenic myotubes display intramembrane charge movements 
which are smaller in amplitude than those of normal myotubes (compare Figs.  1 and 
2).  The immobilization-resistant charge  movements of non-injected dysgenic myo- 
tubes  (Qdys) was  measured  in  a  total  of nine  cells  and  fitted  according  to  Eq.  3, 
yielding average values of Qdy  .....  =  1.8  +-  0.2  nC/~F,  kQ  =  13.3  +  1.3  mV,  and 
VQI/2 =  -11.2  +  2.8 inV. In normal and pCARDl-injected myotubes, Qmax (Table I) 
was  2.8-fold  and  7.6-fold  larger  than  Qdy  ......  respectively.  In  pCAC6-injected 
myotubes,  Q~ax was  3.3  -+  0.5  nC/v.F  (n  =  10),  a  value  only  1.8-fold  larger  than 
Qdys-max. In these cells, it seems likely that Qdys represents an appreciable fraction of 
the  total  immobilization-resistant charge  movement. Thus,  to  reduce  the  possible 
influence of contamination by Qdys on the charge movement parameters in pCAC6- 
injected cells,  data given in Table I  were  averaged only for those  cells expressing 
Qmax >  3.5 nC/~F (n =  4). For these four cells,  VQ~/~ was  -3.5  -+  3.8 mV, whereas 
VQ~/~ averaged -9.3  -+ 2.5 mV for the entire group of ten pCAC6-injected cells. This 
latter value is  quite  close to  the value of VQt/2 in  non-injected  dysgenic cells  (see 
above). 
The  average value  of Q~ax found  in  the  present  experiments  for  normal  and 
pCAC6-injected myotubes are somewhat smaller than the values reported previously 
by Adams et al.  (1990).  One like explanation for this difference is  that the pipette 
solution used for the measurements described here contained only 0.1  mM  EGTA 
instead of the  10 mM used in the earlier work. This lower concentration of EGTA, 
which was  employed in  order to  minimize interference with  the  intracellular  pro- 
cesses  of calcium release  and  reuptake,  permitted  the  cells  to contract vigorously. 
Because such vigorous contractions tended to dislodge the patch pipette, the use of a 
lower EGTA concentration probably biased our experiments towards cells expressing 
fewer DHP receptors and thus a smaller Qmax. 
As expected from earlier work demonstrating that electrically evoked contractions 
are abolished in pCARDl-injected myotubes by manipulations that block the restored 
calcium current  (Tanabe  et al.,  1990a),  the  addition  of Cd z+  +  La  3+  to  the  bath 
completely eliminated the calcium transients in pCARDl-injected myotubes (Fig. 7, 
right hand column). The addition of extracellular Cd 2+  +  La  s+ did not produce such 
pronounced alterations of calcium  transients  in normal  and  pCAC6-injected  myo- 
tubes  (compare  the  left  hand  and  center  columns  of Fig.  7  with  Figs.  1  and  3). 140  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  103  • 1994 
However,  in both  normal and  pCAC6-injected myotubes  exposed to  these  calcium 
channel blockers, the maximal amplitude of the calcium transient was reduced (Table 
I, columns 4 and I0) and the decay of the transient (measured on a longer time-base) 
was accelerated (not shown). Similar effects of Cd  2+  +  La  3+  on calcium transients of 
normal myotubes were described in the previous paper (Garcia and Beam,  1994;  cf 
Fig. 6 A ). In that paper, it was concluded that these effects were unrelated to block of 
calcium current. 
Normal  pCAC6  pCARD  1 
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FIGURE 8.  Comparison of the voltage dependence  of charge  movement,  calcium transient 
and calcium current in normal and  injected myotubes.  For normal myotubes (left), pCAC6- 
injected myotubes (center) and pCARDl-injected myotubes (right), the quantity of ON charge 
moved (&), slow calcium channel conductance (O), and the amplitude of the calcium transient 
measured before (O) or after the addition of Cd  2+  +  La  3+  to the bath (A), are plotted as a 
function  of test potential. As described in  the  text,  only calcium conductance  and  calcium 
transient are  shown  for  pCARDl-injected myotubes.  The  ON  charge  and  ~tF/F data were 
normalized by the maximum value of the respective parameter for each cell and averaged. The 
averaged data were then fitted by Eqs.  2 and 3 as appropriate. For pCAC6-injected cells, the 
averages reflect data only from cells with Qmax >  3.5 nC/I~F. To obtain calcium conductance, 
peak  Ica-V  data for each cell were fitted with Eq.  I to obtain Vr~ and values of conductance were 
calculated  as  Gc,(V)  =  Ic~(V)/(V--Vrev) and  normalized  by  G'~x  for  that  cell  (normal  and 
pCAC6-injected) or by the  average value of Gc~ for  Vm  >  30  mV  (pCARD 1-injected). The 
normalized  values  of  Gc~  were  then  averaged  and  fitted  according  to  Gc~(V)  =  G',~/ 
[1 +  exp {(V~.l/2  -  V)/k'G}]. The midpoint (Vu2) and steepness (k) parameters for the smooth 
curves for normal and  pCAC6-injected myotubes, respectively, are: Qoy,  -0.6 mV and  11.9 
mV,  -3.8  mV  and  14.9  mV;  AF/F,  6.3  mV  and  8.2  mV,  9.2  mV  and  11.8  mV;  AF/F 
(Cd 2+  +  La  ~+ in bath),  13.3  mV and 8.1  mV;  8.1  mV and 9.4 mV; Gca,  19.8 mV and 7.7 mV; 
26.41  mV and 8.9 mV.  For the pCARDl-injected myotubes, V~-~2 and k~, were 0.15  mV and 
4.14 mV, respectively. 
Relationship  Between Charge Movement,  Calcium  Transient and Calcium  Current in 
Normal and Injected Myotubes 
Fig.  8  illustrates,  for  both  normal  myotubes  (left)  and  pCAC6-injected  dysgenic 
myotubes  (center),  the  voltage dependence  of charge  movement  (1),  slow  calcium 
channel conductance (O), and the calcium transient measured before (O) or after (A) GARCiA ET AL.  Ca  2  + Transients for Expressed Skeletal and Cardiac DHPRs  141 
the  addition of Cd 2+  +  La  3+. To allow averaging of data from different cells,  the 
values for charge, fluorescence change and conductance from an individual cell were 
normalized to the maximum value of that parameter. The smooth curves through the 
data points for the slow calcium conductance, calcium transient and charge move- 
ment represent least-squares fits of Eqs.  1,  2, and 3, respectively. Average values of 
the parameters determined by fits of these equations to data from individual cells are 
summarized in Table I. 
In  those  pCARDl-injected  myotubes  where  both  calcium  current  and  charge 
movement were successfully measured, the expressed calcium current was sufficiently 
large (see above) that estimated series resistance errors were no less than 8 mV and in 
some cases much larger. As  a  result, comparison of the voltage dependence of the 
slow calcium conductance and of charge movement (made after block of the calcium 
current) is severely compromised because the total current flow, and attendant series 
resistance error, is very different for the two kinds of measurements. Thus,  for the 
pCARDl-injected  myotubes,  only  the  slow  calcium  conductance  and  the  calcium 
transient measured before addition of Cd  2+  +  La  s+ are shown (Fig. 8, right) because 
these were measured under comparable conditions. Note that the rising phase of the 
curve relating the calcium transient to voltage nearly superimposes on the curve of 
calcium conductance vs voltage, as expected if the transient in pCARD 1-injected cells 
is triggered by calcium entering through the calcium channel. 
The curves relating charge movement to test potential are very similar for normal 
and pCAC6-injected myotubes, as are the curves relating calcium transients to test 
potential (Fig. 8, Table I). Specifically, for both normal and pCAC6-injected cells, the 
curves for calcium  transient  vs  potential  are  steeper  than  the  corresponding  Q-v 
curves and shifted to the right. The G-V curves are shifted still  farther to the right, 
with the shift (VGI/2  --  VQI/2) being 15.6 and 27.5 mV for normal and pCAC6-injected 
myotubes, respectively. A value of VGJ/2  --  VQ~/2 that was  larger in pCAC6-injected 
myotubes than  in  normal  myotubes has  been  described  previously (Adams  et  al., 
1990).  Despite  the  fact that  the  activation of calcium  conductance has  an  altered 
relationship to charge movement in pCAC6-injected myotubes compared to normal 
myotubes, the functional relationship between calcium transient and  charge move- 
ment is similar in pCAC6-injected and normal myotubes (Figs. 7 and 8). 
After  the  addition  of Cd 2+  +  La  3+,  the  curve relating  the  calcium  transient  to 
voltage for normal myotubes was shifted slightly to the right (Fig. 8, Table I). We are 
uncertain  as  to  the  reason  for this  phenomenon.  One  possibility  is  that  the  shift 
results from a time-dependent change in the properties of the myotube, because the 
measurements  with  the  heavy  metals  were  always  made  later  in  the  experiment. 
Alternatively, the shift may be a consequence of the heavy metals entering the cell. In 
support of the latter possibility, we noted that the addition of the heavy metals caused 
an  increase  in  basal  fluorescence which  occurred more  rapidly  in  cells  expressing 
higher  densities  of slow  calcium  current.  The  fact  that  pCAC6-injected  myotubes 
express a lower density of slow calcium current than normal myotubes may explain 
why  there was  no  shift  of the  curve  relating  the  transient  to voltage  for injected 
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DISCUSSION 
pCAC6- and pCARDl-injected Myotubes Mimic e-c Coupling of Skeletal or Cardiac 
Muscle, Respectively 
In this paper, we have compared the properties of intracellular calcium transients, 
calcium currents  and  intramembrane  charge movements  measured  simultaneously 
with fluorometry and whole-cell patch clamping  in  normal  myotubes and  dysgenic 
myotubes injected with pCAC6 or pCARD 1, cDNAs encoding the skeletal muscle or 
cardiac DHP receptor, respectively. In both normal and pCAC6-injected myotubes, 
the  amplitude  of the  calcium  transient  increased  sigmoidally as  a  function of test 
potential,  saturating for strong depolarization. Also in both types of myotubes, an 
intracellular  calcium  transient  was  still  present  after  block  of the  DHP-sensitive 
current. Thus, both the endogenous and expressed skeletal muscle DHP receptor are 
able to function as a voltage sensor which can elicit the release of calcium from the SR 
in a  direct fashion that does not require the entry of extracellular calcium.  In this 
respect, as well as  in  respect to  the  inter-relationships between charge  movement, 
calcium  transient  and  calcium  current,  normal  and  pCAC6-injected  myotubes re- 
semble adult frog skeletal muscle fibers (Chandler et al.,  1976;  Miledi,  Parker,  and 
Zhu,  1984;  Melzer,  Schneider,  Simon,  and  Sziics,  1986;  Brum,  Stefani,  and  Rios, 
1987; Simon and Schneider,  1988; Garcla, Amador, and Stefani, 1989). 
In  dysgenic  myotubes  injected  with  pCARD1,  the  amplitude  of  the  calcium 
transient showed a  bell-shaped dependence on test potential,  mirroring the ampli- 
tude of the  DHP-sensitive current.  Blocking the  calcium current,  completely abol- 
ished the calcium transient in pCARD 1-injected myotubes. Several lines of evidence 
support the idea that the calcium transient in pCARDl-injected myotubes predomi- 
nantly reflects calcium released from the SR, rather than just resulting from the entry 
of external calcium. First, some pCARDl-injected cells display large calcium currents 
(Fig. 4 B,  see below) but no detectable transient or electrically-evoked contraction. 
Second, we  have previously shown  that  following caffeine treatments,  expected to 
deplete  partially  the  SR  of calcium,  contractions become stronger with  successive, 
identical voltage-clamp commands even though the amplitude of the calcium current 
remained  constant  (Tanabe  et  al.,  1990a).  Taken  together,  these  observations 
support the idea that the cardiac DHP receptor expressed in dysgenic myotubes is 
unable to function as a voltage sensor but is able to function as a calcium channel, 
which elicits calcium-induced calcium release from the SR. Thus,  pCARDl-injected 
myotubes mimic cardiac muscle cells (Fabiato,  1985; N~bauer et al.,  1989). 
Presence of Calcium Current in Noncontracting Myotubes 
Interestingly, some dysgenic myotubes injected with pCAC6  or pCARD1  expressed 
significant calcium current but did not show electrically evoked contractions and/or 
an appreciable calcium transient. For example, out of 48 dysgenic cells injected with 
pCAC6 (three separate cultures), 14 were found to contract and all of these expressed 
slowly activating calcium current, with an average peak density of -3.9 -+ 0.8 pA/pF. 
Of the 34 noncontracting cells, 28 did not express measurable slow calcium current. 
However,  six  of  these  noncontracting  cells  expressed  slowly  activating  calcium 
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cells, the expressed skeletal DHP receptor functioned both as a calcium channel and 
as a voltage sensor. Perhaps, in the cells expressing current but no contraction, the 
newly synthesized DHP receptors were not localized correctly with respect to, or had 
not yet established a  functional connection with, the calcium release channel of the 
SR. However, we cannot exclude the possibility that the failure to contract was due to 
immaturity  of the  SR  or  contractile  apparatus.  Compared  to  dysgenic  myotubes 
transfected with pCAC6,  many more of those  transfected with pCARD1  expressed 
current but  not  electrically-evoked contraction. Although  not  examined  systemati- 
cally,  we  did  observe  in  two  separate  cultures  that  about  half  of  the  dysgenic 
myotubes transfected with  pCARD1  by CaPO4  precipitation  (Chen  and  Okayama, 
1988) displayed appreciable cardiac-like calcium current (-12.6 +  2.5 pA/pF, n  =  8) 
but did not contract. An example of a  pCARDl-injected myotube expressing large 
calcium current but no calcium transient is illustrated in Fig. 4 B. The observation of 
a  higher  fraction of noncontracting myotubes expressing  cardiac  calcium  current 
than  of noncontracting myotubes expressing  skeletal  muscle  calcium  current  may 
indicate that the process that directs the co-localization of the DHP receptor and the 
release channel is more tightly coupled for the skeletal muscle DHP receptor than for 
the cardiac DHP receptor. 
A  Simple Model for the Function  of a  DHP Receptor as  Voltage  Sensor and 
Calcium  Channel 
Based  on  the  data  presented in  this  paper on  normal  and  injected myotubes,  on 
similar data obtained from fibers of adult frog skeletal muscle (Chandler et al.,  1976; 
Melzer et al.,  1986;  Brum et al.,  1987;  Simon and  Schneider,  1988;  Garcla et al., 
1989), and experimental analysis of chimaeric DHP receptors (Tanabe et al.,  1990b; 
Tanabe, Adams, Numa, and Beam, 1991), we present the model in Fig. 9. The model 
is  suggested as a  simple  scheme in which conformational changes of an individual 
DHP  receptor  can  account  for  the  inter-relationships,  in  both  time  and  voltage 
dependence, between charge movement, calcium transient and slow calcium current. 
For simplicity, the model shows the ryanodine receptor (RyR), the putative SR release 
channel  (Fleischer, Ogunbunmi,  Dixon,  and  Fleer,  1985;  Lai,  Erickson,  Rousseau, 
Liu, and Meissner,  1988; Smith, Imagawa, Ma, Fill, Campbell, and Coronado, 1988), 
as  interacting with  a  single  DHP  receptor,  although  both  morphological  (Block, 
Imagawa,  Campbell,  and  Franzini-Armstrong,  1988) and  physiological (Simon and 
Hill,  1992) analyses are consistent with the idea that activation of calcium release is 
controlled cooperatively by four DHP receptors (one DHP receptor interacting with 
each of the four subunits of the RyR). 
In the model, the opening and closing of the RyR is controlled by the conforma- 
tional state of the putative cytoplasmic loop (the "II-III loop") linking repeats II and 
III  of the  DHP  receptor,  an  idea  motivated  by  previous work  in  which  putative 
cytoplasmic regions  of the  cardiac  DHP  receptor were replaced by corresponding 
regions of the skeletal muscle DHP receptor (Tanabe et al.,  1990b). However, other 
cytoplasmic regions might also interact with the RyR. Such regions probably would 
not have been revealed by the experiments of Tanabe et al.  (1990b) if their amino 
acid sequence were similar in the skeletal and cardiac muscle DHP receptors. Based 
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cardiac chimaeric DHP receptor has skeletal  muscle sequence (Tanabe et al.,  1991), 
repeat I is illustrated as the last to undergo a conformational change in order to open 
the channel.  Determining the voltage dependence of this conformational change will 
require  single channel measurements.  A  model in which a  conformational change of 
repeat  I  is  rate-limiting  for channel  opening  has  been used  by Feldmeyer,  Melzer, 
Pohl, and Z611ner (1992) to account for the effects of strongly depolarizing prepulses 
on kinetics of activation of calcium current in frog skeletal muscle. 
Dihydropyridine receptor 
C~  >C~  >C(  :)-0 
Extracellular 
T4t 
Myoplasmic 
SR 
Luminal 
C<  =C  ~  =0(  }'0 
Ryanodine  receptor 
FIGURE 9.  A simple model of the DHP receptor functioning as both a voltage sensor and a 
calcium channel. The model depicts the DHP receptor within the T-tubule membrane and the 
ryanodine receptor in the neighboring SR membrane. The four homology repeats (Tanabe et 
al.,  1987) are indicated by Roman numerals; for simplicity,  the homotetrameric structure (Lai 
et al.,  1988; Wagenknecht, Grassucci,  Frank, Saito,  Inui, and Fleischer,  1989)of the ryanodine 
receptor is not shown.  Plus  signs on the DHP receptor are meant to indicate the presence of 
positively  charged residues (Tanabe et al.,  1987). The ieftmost panel indicates the resting state 
in  which  the  myoplasmic face  of the  T-tubule  is  polarized  negatively  with  respect  to  the 
extracellular face. The rightmost three panels illustrate conformational alterations of the DHP 
receptor and ryanodine receptor that are caused by T-tubular depolarization.  Closed (C) and 
open  (O)  states  are  indicated  both  for  the  dihydropyridine  receptor  and  the  ryanodine 
receptor. For further details,  see text. 
The model in Fig.  9 can account for important experimental  observations on the 
interrelationships  between charge movement, calcium transient and calcium current. 
The leftmost state represents  the resting configurations and both the DHP receptor 
and  the  RyR  are  closed  to  the  flow  of  ions.  Upon  depolarization,  the  system 
undergoes  a  sequence  of conformation changes proceeding  from left  to right.  The 
initial  voltage-driven  conformational  change  (movement  from  leftmost  state  to 
adjoining state) is arbitrarily illustrated  as occurring in repeat II. This conformational GARCfA ~T AL.  Ca e+ Transients for Expressed Skeletal and Cardiac DHPRs  145 
change (illustrated as a  simple translocation across the T-tubule membrane) would 
generate intramembrane charge movement but would not cause the altered configu- 
ration of the II-III loop necessary to open the RyR. Thus, this conformational change 
is one way to account for the movement of charge that precedes intracellular calcium 
release  temporally (see  Figs.  1 and  3)  and  for the  charge  that  moves  for weaker 
depolarizations than required to elicit calcium release (Fig. 8). When both repeats II 
and  III  have undergone  a  voltage-driven conformational change  (third  state  from 
left), the altered configuration of the II-III loop causes the RyR to open, although the 
DHP-sensitive channel is  still  closed.  (For simplicity, the conformational change of 
repeat  IV  is  shown  to  occur  simultaneously  with  that  of repeat  III).  Finally,  a 
conformational  change  in  repeat  I  causes  the  channel  to  open.  Thus,  channel 
opening occurs later in time, and requires stronger depolarization, than the activa- 
tion of the RyR (Figs.  1, 3, and 8). 
Although the model of Fig. 9 is incomplete, it is useful in that it summarizes many 
experimental observations and in that it provides a conceptual framework for future 
experiments. For example, it predicts that mutations introduced into repeat I could 
affect the voltage dependence and kinetics of calcium current with little or no effect 
on calcium release. Mutations introduced into repeats II or III would be expected to 
most strongly affect voltage dependence and/or kinetics of charge movements and 
calcium transients, with much less effect on the current. 
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